Literature DB >> 14470881

A comparison of the effect of prednisone and a placebo in the treatment of multiple myeloma.

R E MASS.   

Abstract

Entities:  

Keywords:  MYELOMA, PLASMA CELL/therapy; PREDNISONE/therapy

Mesh：

Substances：

Year:  1962        PMID： 14470881

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  9 in total

1.  THE EFFECT OF PREDNISONE ON CALCIUM METABOLISM AND CA47 KINETICS IN PATIENTS WITH MULTIPLE MYELOMA AND HYPERCALCEMIA.

Authors:  C J BENTZEL; P P CARBONE; L ROSENBERG
Journal:  J Clin Invest       Date:  1964-11       Impact factor: 14.808

2.  [DURATION OF DISEASE AND SURVIVAL TIME IN MULTIPLE MYELOMA].

Authors:  P OBRECHT; E KALLITERAKIS; D KLEMM
Journal:  Klin Wochenschr       Date:  1963-09-15

3.  Multiple myeloma.

Authors:  W A SKOOG; W S ADAMS
Journal:  Calif Med       Date:  1963-08

Review 4.  Multiple myeloma.

Authors:  S Vincent Rajkumar
Journal:  Curr Probl Cancer       Date:  2009 Jan-Feb       Impact factor: 3.187

5.  [Life prognosis of treated and non-treated patients with plasmacytoma].

Authors:  C Ramsbott; H Gerhartz; P Obrecht
Journal:  Blut       Date:  1967-01

Review 6.  Multiple myeloma.

Authors:  Robert A Kyle; S Vincent Rajkumar
Journal:  Blood       Date:  2008-03-15       Impact factor: 22.113

7.  Efficacy of prednisone in refractory multiple myeloma and measurement of glucocorticoid receptors. A Southwest Oncology Group study.

Authors:  V Gupta; E B Thompson; D Stock-Novack; S E Salmon; H I Pierce; J D Bonnet; D Chilton; J Beckford
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

8.  Thalidomide and its analogues in the treatment of Multiple Myeloma.

Authors:  Tahir Latif; Nabeel Chauhan; Rashid Khan; Andrea Moran; Saad Z Usmani
Journal:  Exp Hematol Oncol       Date:  2012-09-11

9.  Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS).

Authors:  Li Pang; S Vincent Rajkumar; Prashant Kapoor; Francis Buadi; Angela Dispenzieri; Morie Gertz; Martha Lacy; Robert Kyle; Shaji Kumar
Journal:  Blood Cancer J       Date:  2021-02-01       Impact factor: 11.037
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.